By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Contact Information

Website: www.curis.com
Email: info@curis.com
Main Phone: +1 617 503-6500
Address: 128 Spring Street
Address 2: Building C - Suite 500
State: MA
City / Town: Lexington
Country: US
Postal Code: 02421

Issuer Information

Exchange: NSD
CEO: James E. Dentzer
Employees: 28
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A